{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Brooksville",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64188",
      "recalling_firm": "TG United, Inc.",
      "address_1": "16275 Aviation Loop Dr",
      "address_2": "N/A",
      "postal_code": "34604-6805",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "FL, MS, SC, LA  and TX",
      "recall_number": "D-524-2013",
      "product_description": "BroveX PSE, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Pernix Therapeutics, Gonzales, LA 70737 NDC 58605-440-01",
      "product_quantity": "10,036 bottles - 100-count tablets",
      "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.",
      "recall_initiation_date": "20130130",
      "center_classification_date": "20130604",
      "termination_date": "20160930",
      "report_date": "20130612",
      "code_info": "Lot# 11A001  Exp. 12/12; Lot# 11L002  Exp. 10/13; Lot # 12K007 Exp. 09/14."
    }
  ]
}